Cibus CEO foretells gene editing and bioinformatics to target peanut allergens

December 09, 2019 | Case Study

Crop and livestock trait development with gene editing (GE) is on the mind of every business across the agriculture industry. Peter Beetham (CEO of Cibus) provided a recent and optimistic opinion in Scientific American. Cibus (Lux Take: Positive) is a well-funded GE trait developer employing gene repair oligonucleotides (GRON) to improve the precision of tools like TALEN and CRISPR/Cas by avoiding the associated repair errors. Cibus holds patents for the technology and is among the few developers with a commercialized gene-edited trait: sulfonylurea resistance in canola. Peter shared a view of overcoming human health issues associated with food through the confluence of GE and bioinformatics for crop development, starting with peanuts.